基于EOS计算器的协议的实施降低了婴儿在胆 ?? 膜炎中的抗生素暴露,而与胎盘组织病理无关
Tonya Robinson1, Kimberly Knott1, Zhanxu Liu2
1Department of Pediatrics, Division of Neonatology, University of Louisville School of Medicine, Louisville, KY, USA.
概括
早期发作的败血症 (EOS) 计算器显著降低了新生儿暴露于母体胆膜炎的抗生素暴露. 这种计算器引导的方法没有错过任何EOS病例,也没有显示与胎盘病理发现的相关性.
科学领域:
- 新生儿医学 新生儿医学
- 传染性疾病 传染性疾病
- 临床信息学 临床信息学
背景情况:
- 临床膜炎在新生儿中构成早期发作的败血症 (EOS) 的风险.
- 由于潜在的不良影响,新生儿接触抗生素是令人担忧的.
- 需要标准化的协议来指导在高危婴儿的抗生素使用.
研究的目的:
- 评估早期发作的败血症 (EOS) 计算器对患有临床胆炎的母亲生下的婴儿抗生素暴露的影响.
- 评估EOS计算器建议与胎盘组织病理学发现之间的相关性.
主要方法:
- 一项回顾性观察性研究比较了两组婴儿 (怀孕≥36周) 暴露于母亲临床膜炎.
- 第1组 (n=69) 在实施EOS计算器之前接受了护理,而第2组 (n=139) 在实施后接受了护理.
- 婴儿抗生素暴露和胎盘病理使用曼·惠特尼和奇方测试进行了分析.
主要成果:
- 在2组与1组相比,观察到抗生素暴露的统计显著下降 (p < 0.001).
- EOS计算器协议成功识别了所有EOS病例,没有一个错过.
- 根据EOS计算器指导的抗生素治疗与胎盘组织病理学结果之间没有发现显著的相关性 (p = 0.966).
结论:
- 根据研究人群量身定制的EOS计算器协议的实施有效地减少了新生儿对抗生素的暴露.
- 该研究发现,EOS计算器引导的抗生素管理与胆肌炎的组织学证据之间没有联系.
- EOS计算器是优化新生儿护理中的抗生素管理的宝贵工具.
更多相关视频
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
3.7K
06:51Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
Published on: July 28, 2023
1.2K
相关概念视频
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...